UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation

The New England journal of medicine, 2021-01, Vol.384 (4), p.305-315

2021

Volltextzugriff (PDF)

Progression of Atrial Fibrillation after Cryoablation or Drug Therapy

The New England journal of medicine, 2023-01, Vol.388 (2), p.105-116

2023

Volltextzugriff (PDF)

Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation

The New England journal of medicine, 2013-05, Vol.368 (22), p.2084-2093

2013

Volltextzugriff (PDF)

Class I and Class III Antiarrhythmic Agents: Mechanisms of Action and the Problem of Proarrhythmic Activity

McGill journal of medicine, 2020-12, Vol.1 (2)

Essebag, Vidal

2020

Volltextzugriff (PDF)

Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs

The New England journal of medicine, 2016-07, Vol.375 (2), p.111-121

2016

Volltextzugriff (PDF)

Atrial Fibrillation Burden: Impact on Stroke Risk and Beyond

Medicina (Kaunas, Lithuania), 2024-04, Vol.60 (4), p.536

2024

Volltextzugriff (PDF)

Long‐term outcomes of catheter ablation for atrial fibrillation: It's a matter of time

Journal of cardiovascular electrophysiology, 2020-05, Vol.31 (5), p.1048-1050

2020

Volltextzugriff (PDF)

Prevention of Arrhythmia Device Infection Trial: The PADIT Trial

Journal of the American College of Cardiology, 2018-12, Vol.72 (24), p.3098-3109

2018

Volltextzugriff (PDF)

Maximizing biventricular pacing in patients with rate‐controlled atrial fibrillation using ventricular sense response

Pacing and clinical electrophysiology, 2019-07, Vol.42 (7), p.1069-1072

2019

Volltextzugriff (PDF)

Population‐level evaluation of complications after catheter ablation in patients with atrial fibrillation and heart failure

Journal of cardiovascular electrophysiology, 2019-12, Vol.30 (12), p.2678-2685

2019

Volltextzugriff (PDF)

Catheter ablation for atrial fibrillation in heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials

BMC cardiovascular disorders, 2019-01, Vol.19 (1), p.18-18, Article 18

2019

Volltextzugriff (PDF)

Predicting response to cardiac resynchronization therapy: Use of strict left bundle branch block criteria

Pacing and clinical electrophysiology, 2019-04, Vol.42 (4), p.431-438

2019

Volltextzugriff (PDF)

A randomized clinical trial of early invasive intervention for atrial fibrillation (EARLY-AF) - methods and rationale

The American heart journal, 2018-12, Vol.206, p.94-104

2018

Volltextzugriff (PDF)

The Optimal Anti-Coagulation for Enhanced-Risk Patients Post–Catheter Ablation for Atrial Fibrillation (OCEAN) trial

The American heart journal, 2018-03, Vol.197, p.124-132

2018

Volltextzugriff (PDF)

Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial

The American heart journal, 2016-03, Vol.173, p.102-107

2016

Volltextzugriff (PDF)

TCT-376 Randomized Trial of Conventional Transseptal Needle Versus Radiofrequency Energy Needle Puncture for Left Atrial Access During Cryoballoon Ablation (CRYO-LATS Study)

Journal of the American College of Cardiology, 2019-10, Vol.74 (13), p.B373-B373

2019

Volltextzugriff (PDF)

Subclinical Atrial Fibrillation and Risk of Stroke: Past, Present and Future

Medicina (Kaunas, Lithuania), 2019-09, Vol.55 (10), p.611

2019

Volltextzugriff (PDF)

OCEAN trial update

The American heart journal, 2022-06, Vol.248, p.169-169

2022

Volltextzugriff (PDF)

Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale

The American heart journal, 2022-12, Vol.254, p.133-140

2022

Volltextzugriff (PDF)

Relation of Digoxin Use in Atrial Fibrillation and the Risk of All-Cause Mortality in Patients ≥65 Years of Age With Versus Without Heart Failure

The American journal of cardiology, 2014-08, Vol.114 (3), p.401-406

2014

Volltextzugriff (PDF)

High‐power short‐duration versus low‐power long‐duration ablation for pulmonary vein isolation: A substudy of the AWARE randomized controlled trial

Journal of cardiovascular electrophysiology, 2024-01, Vol.35 (1), p.136-145

2024

Volltextzugriff (PDF)

Augmented wide area circumferential catheter ablation for reduction of atrial fibrillation recurrence (AWARE) trial: Design and rationale

The American heart journal, 2022-06, Vol.248, p.1-12

2022

Volltextzugriff (PDF)

Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure

BMC medical research methodology, 2005-01, Vol.5 (1), p.5-5, Article 5

2005

Volltextzugriff (PDF)

Meta-Analysis Comparing Neurohumoral Antagonist Use in Patients ≥75 Years Versus <75 Years Receiving Cardiac Resynchronization Therapy

The American journal of cardiology, 2018-04, Vol.121 (8), p.975-980

2018

Volltextzugriff (PDF)

1 – 25 von 279

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(260)
Mit Volltextzugriff
(256)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(184)
Life Sciences & Biomedicine
(183)
Cardiovascular System & Cardiology
(153)
Cardiac & Cardiovascular Systems
(151)
Humans
(147)
Male
(82)
Female
(79)
Aged
(72)
Cardiac Arrhythmia
(57)
Cardiovascular
(51)
Middle Aged
(50)
Risk Factors
(48)
Catheter Ablation
(44)
Treatment Outcome
(44)
Atrial Fibrillation
(41)
Ablation
(30)
Stroke
(30)
Cardiology
(29)
Catheter Ablation - Methods
(27)
Atrial Fibrillation - Surgery
(26)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation

Progression of Atrial Fibrillation after Cryoablation or Drug Therapy

Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation

Class I and Class III Antiarrhythmic Agents: Mechanisms of Action and the Problem of Proarrhythmic Activity

Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs

Atrial Fibrillation Burden: Impact on Stroke Risk and Beyond

Long‐term outcomes of catheter ablation for atrial fibrillation: It's a matter of time

Prevention of Arrhythmia Device Infection Trial: The PADIT Trial

Maximizing biventricular pacing in patients with rate‐controlled atrial fibrillation using ventricular sense response

Population‐level evaluation of complications after catheter ablation in patients with atrial fibrillation and heart failure

Catheter ablation for atrial fibrillation in heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials

Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial

Predicting response to cardiac resynchronization therapy: Use of strict left bundle branch block criteria

A randomized clinical trial of early invasive intervention for atrial fibrillation (EARLY-AF) - methods and rationale

The Optimal Anti-Coagulation for Enhanced-Risk Patients Post–Catheter Ablation for Atrial Fibrillation (OCEAN) trial

Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial

TCT-376 Randomized Trial of Conventional Transseptal Needle Versus Radiofrequency Energy Needle Puncture for Left Atrial Access During Cryoballoon Ablation (CRYO-LATS Study)

Subclinical Atrial Fibrillation and Risk of Stroke: Past, Present and Future

OCEAN trial update

Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale

Relation of Digoxin Use in Atrial Fibrillation and the Risk of All-Cause Mortality in Patients ≥65 Years of Age With Versus Without Heart Failure

High‐power short‐duration versus low‐power long‐duration ablation for pulmonary vein isolation: A substudy of the AWARE randomized controlled trial

Augmented wide area circumferential catheter ablation for reduction of atrial fibrillation recurrence (AWARE) trial: Design and rationale

Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure

Meta-Analysis Comparing Neurohumoral Antagonist Use in Patients ≥75 Years Versus <75 Years Receiving Cardiac Resynchronization Therapy

Suchergebnisse filtern